Ankylosing spondylitis is an inflammatory disorder affecting the axial skeleton and periphery. Symptoms can often be debilitating. Current therapy for the disease include physical therapy, non-steroidal anti-inflammatory drugs (NSAIDS, anti-rheumatic disease modifying drugs (DMARDS), and the newly developed biologic agents targeting tumor necrosis factor alpha (TNF-α). This paper will provide a comprehensive review of these treatments which focusing on evidence based medicine for the daily clinical practice of rheumatology.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Received: 31 December 2002 / Accepted: 15 January 2003
Correspondence to J.C. Davis Jr.
About this article
Cite this article
Scalapino, K., Davis Jr., J. The treatment of ankylosing spondylitis. Clin Exp Med 2, 159–165 (2003). https://doi.org/10.1007/s102380300000